Kewaunee Scientific Corporation · NASDAQ:KEQU

Kewaunee Scientific — Shareholder Meeting (August 2020)

22 slides from Kewaunee Scientific's shareholder meeting presentation, Aug 26, 2020

  1. Slide 1: Kewaunee Scientific Corporation

    Kewaunee Scientific Corporation NASDAQ: KEQU encouraging new discovery…Worldwide Exhibit 99.1

  2. Slide 2: Special Note Regarding Forward-Looking Statements

    Special Note Regarding Forward-Looking Statements Certain statements in this document constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). All statements other than statements of historical fact included in this docume

  3. Slide 3: Agenda

    Kewaunee Scientific Corporation | NASDAQ: KEQU Agenda Kewaunee Scientific Overview Fiscal Year 2020 Review Outlook and Strategic Direction Q&A

  4. Slide 4: Overview

    Kewaunee Scientific Corporation | NASDAQ: KEQU Kewaunee Scientific Overview

  5. Slide 5: Kewaunee Scientific Overview: leading designer and manufacturer of laboratory equipment

    Kewaunee Scientific Corporation | NASDAQ: KEQU Kewaunee is a leading global designer, manufacturer, and installer of specialized equipment and technical furniture products for laboratories across an array of industries, including life sciences, education, government, healthcare, and general research

  6. Slide 6: Industries served receive prioritization for investment dollars

    Kewaunee Scientific Corporation | NASDAQ: KEQU The industries served by Kewaunee continue to receive prioritization for investment dollars as companies, governments, and institutions look to encourage discovery that is dependent on investment in research and development. Kewaunee Scientific Overview

  7. Slide 7: Active in multiple sectors with end-market diversification

    Kewaunee Scientific Corporation | NASDAQ: KEQU Kewaunee is active in multiple sectors, providing geographical and industry diversification. The diversity of end-use segments for the Company’s products supports a narrative of growth and end-market expansion for Kewaunee. Kewaunee Scientific Overview

  8. Slide 8: North American leader in laboratory, healthcare and technical furniture

    Kewaunee Scientific Corporation | NASDAQ: KEQU Kewanee is a North American leader in manufactured laboratory, healthcare, and technical furniture. Domestically, the company primarily relies on its dealer and distribution network to sell its products to end users. Kewaunee Scientific Overview Designs

  9. Slide 9: International turn-key laboratory solutions, leading in India and Middle East

    Kewaunee Scientific Corporation | NASDAQ: KEQU Internationally, Kewaunee participates throughout the entire laboratory build and operate value chain from pre-construction through post-construction with market leading positions in India and the Middle East Kewaunee Scientific Overview Turn-key provid

  10. Slide 10: FY 2020 Review

    Kewaunee Scientific Corporation | NASDAQ: KEQU FY 2020 Review

  11. Slide 11: FY 2020 Review – Consolidated Results

    Kewaunee Scientific Corporation | NASDAQ: KEQU FY 2020 Review – Consolidated Results

  12. Slide 12: FY 2020 Review – Enhancements to External Reporting

    Kewaunee Scientific Corporation | NASDAQ: KEQU FY 2020 Review – Enhancements to External Reporting Enhancing quarterly reporting by including consolidated EBITDA and segment EBITDA to provide additional insights into the operating performance of the Company’s segments. EBITDA and segment EBITDA are

  13. Slide 13: FY 2020 Review – Domestic Segment

    Kewaunee Scientific Corporation | NASDAQ: KEQU FY 2020 Review – Domestic Segment FY 2020 Impacts: Large Middle East order manufactured in the US at negative margins. Restructuring costs incurred during Q2. Significant one-time costs during the FY. Investment in resources focused on muti-year system

  14. Slide 14: FY 2020 Review – International Segment

    Kewaunee Scientific Corporation | NASDAQ: KEQU FY 2020 Review – International Segment FY 2020 Impacts: Large strategic Middle East project taken aggressively in prior fiscal year. Withholding tax expense. Closure of China sales office. COVID-19 impacts to cost, productivity and access to constructio

  15. Slide 15: Strategic Direction and Outlook

    Kewaunee Scientific Corporation | NASDAQ: KEQU Strategic Direction and Outlook

  16. Slide 16: Strategic Direction and Outlook

    Kewaunee Scientific Corporation | NASDAQ: KEQU Strategic Direction and Outlook

  17. Slide 17: To be the global supplier of choice in laboratory furniture and infrastructure

    “To be the global supplier of choice with customers in the laboratory furniture and infrastructure markets.” Kewaunee Scientific Corporation | NASDAQ: KEQU Strategic Direction and Outlook

  18. Slide 18: Outlook and Strategic Vision: Our Guiding Principles

    Kewaunee Scientific Corporation | NASDAQ: KEQU Outlook and Strategic Vision We will be easy to do business with We will get closer to our customer(s) We will lead and not follow (we are innovators) Our Guiding Principles We will do everything with excellence

  19. Slide 19: Outlook and Strategic Vision

    Near term, COVID-19 will continue to impact the rate of activity in the marketplace and the pace of construction activity. Long term, COVID-19 will result in investments in infrastructure that require Kewaunee’s products. Continue investing in domestic technology infrastructure. Re-capitalization of

  20. Slide 20: Thank You and Questions

    Kewaunee Scientific Corporation | NASDAQ: KEQU Thank You and Questions

  21. Slide 21: Appendix

    Kewaunee Scientific Corporation | NASDAQ: KEQU Appendix

  22. Slide 22: Non-GAAP Reconciliations

    Kewaunee Scientific Corporation | NASDAQ: KEQU Non-GAAP Reconciliations Kewaunee Scientific Corporation Kewaunee Scientific Corporation Annual Shareholder Meeting | August 26, 2020 Appendix: Non-GAAP Measures (Dollars in Thousands) The following unaudited tables reconcile Net Earnings to EBITDA, by

Kewaunee Scientific — Shareholder Meeting (August 2020) on 6ix